Inovio Stock Roiled As Citron Research, Law Firms Push Back On Coronavirus Vaccine AnnouncementBenzinga • 03/13/20
Why Inovio Pharmaceuticals Is a Top Stock to Watch Amid the Coronavirus PandemicThe Motley Fool • 03/13/20
Inovio Pharmaceuticals downgraded by RBC after gaining more than 180% on coronavirus vaccine hopesMarket Watch • 03/13/20
INOVIO Pharmaceuticals, Inc. (INO) CEO J. Joseph Kim on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/13/20
Inovio Gets $5 Million From Gates Foundation for a Device to Deliver Its Coronavirus VaccineThe Motley Fool • 03/12/20
Why Alpha Pro Tech, Co-Diagnostics, and Inovio Pharmaceuticals Are on Fire TodayThe Motley Fool • 03/12/20